hotspot -WSS

hotspot

author：leisure time 2025-09-30 01:01:55 - browse：38527

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Streamlined flu vaccines recommended by FDA advisory panel

WSS

New rules on organ donation and transplantation 'will bring chaos'

Stem cell biologist probes earliest stages of human development

A double vaccine crisis is endangering millions of children

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Stem cell biologist probes earliest stages of human development

focus

hotspot

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AbbVie dramatically boosts its spending on lobbying

Medicare details structure of new drug price negotiation program

Families look for replacement for GSK asthma drug Flovent

Peter Hotez and the public health issue of online harassment

Families look for replacement for GSK asthma drug Flovent

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ozempic has benefits for kidney disease as well as diabetes

How one medical school became remarkably diverse

In new study, freeze

hotspot

CDC backtracks, saying fully vaccinated people can go maskless indoors

Longer MASH drug regimen improved liver, Akero study finds

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Streamlined flu vaccines recommended by FDA advisory panel

$1 billion proposal to grow Boston, Massachusetts biotech

Lack of health data on LGBTQ+ people has serious consequences

focus

Wikipedia

explore

hotspot